Conditions: Breast Neoplasms
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 298
Healthy volunteers: no

Brief summary:
To verify the non-inferiority of exemestane compared to anastrozole in time to tumor progression (TTP), the primary efficacy endpoint, in postmenopausal women with advanced/recurrent breast cancer.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: exemestane intervention 2: anastrozole
Intervention descriptions: intervention 1: take orally one tablet per day of exemestane 25 mg and one tablet per day of anastrozole placebo daily after meal intervention 2: take orally one tablet of anastrozole 1 mg and one tablet of exemestane placebo daily after meal

Protocol document: